NCT00734305 2016-09-01Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary TreatmentMerrimack PharmaceuticalsPhase 1 Completed44 enrolled 12 charts
NCT00730470 2010-07-29Phase I Study of U3P1287/01, Including Patients With Advanced Solid TumorsU3 Pharma GmbHPhase 1 Completed60 enrolled